Mycolog-II: Indications and Use
Mycolog-II (nystatin and triamcinolone acetonide) is a topical combination antifungal-corticosteroid cream used to treat superficial fungal skin infections, particularly cutaneous candidiasis (yeast infections of the skin) in areas like skin folds and flexures.
Primary Indication
The combination provides dual action:
- Nystatin treats the fungal infection (specifically Candida species)
- Triamcinolone acetonide (a corticosteroid) reduces inflammation, itching, and redness
Application Guidelines
According to FDA labeling 1:
- Apply to affected area 3-4 times daily maximum
- Approved for adults and children ≥12 years old
- Children under 12 require physician consultation
- Wash hands after application (unless treating hands)
Important Clinical Considerations
Evidence-Based Concerns
Current evidence suggests this combination is actually less cost-effective than single-agent antifungals 2. Despite this, practitioners continue prescribing combination agents, though the evidence doesn't support superiority over nystatin alone.
When This Product May Be Appropriate
The combination showed equal efficacy to nystatin alone in treating candidal flexural infections, with a trend toward faster symptom relief (though not statistically significant) 3. The corticosteroid component may provide:
- More rapid symptomatic relief of itching and inflammation
- Patient preference due to faster comfort (not cure)
Critical Pitfalls to Avoid
- Do not use for dermatophyte infections (ringworm, athlete's foot) - nystatin only treats Candida
- Avoid prolonged use - corticosteroids can cause skin atrophy, striae, and may actually worsen fungal infections if used too long
- Not first-line therapy - single-agent antifungals are preferred per current evidence
- More expensive without proven superior efficacy 2
Better Alternatives
For most superficial candidal infections, consider:
- Topical azoles alone (clotrimazole, miconazole) - equally or more effective without corticosteroid risks
- Nystatin alone - if cost is a concern and azoles unavailable
- Reserve combination products for cases with significant inflammation where rapid symptomatic relief is prioritized over cost-effectiveness